Literature DB >> 26609458

Leclercia adecarboxylata Musculoskeletal Infection in an Immune Competent Pediatric Patient: An Emerging Pathogen?

W Jeffrey Grantham1, Shawn S Funk1, Jonathan G Schoenecker2.   

Abstract

Case. An immune competent pediatric patient presented with a persistent lower extremity infection with Leclercia adecarboxylata after a penetrating injury. This case report details the presentation, clinical course, and treatment. Conclusion. Leclercia adecarboxylata has increasing reports in immunosuppressed and adult patients with musculoskeletal infection. This case now indicates that Leclercia adecarboxylata is a potential pathogen in immune competent children in musculoskeletal tissue.

Entities:  

Year:  2015        PMID: 26609458      PMCID: PMC4644830          DOI: 10.1155/2015/160473

Source DB:  PubMed          Journal:  Case Rep Orthop        ISSN: 2090-6757


1. Introduction

As a member of the Enterobacteriaceae family, Leclercia adecarboxylata is a motile Gram negative rod. First described in 1962, its description in the literature is isolated to case reports [1, 2]. Leclercia adecarboxylata is regarded as normal gut flora for animals and has been isolated in human stool. The bacterium is primarily reported in immunosuppressed patients or polymicrobial infections [3]. There have been no case reports of Leclercia adecarboxylata in an immunocompetent musculoskeletal infection in a child. We present a case of foot infection associated with a foreign body by Leclercia adecarboxylata in an immunocompetent pediatric patient.

2. Case Report

A 9-year-old girl stepped on debris in a corn field while playing near a lake. She noted a penetrating injury to the left foot and presented to outside hospital where a foreign body was removed and was started on antibiotics. Foot pain persisted without systemic symptoms. Four days after the injury, pain persisted and she was taken to the operating suite for formal irrigation and debridement by an orthopaedic surgeon. The procedure removed a more substantial foreign body and a wick was placed in the wound. She completed three separate courses of antibiotics including cefalexin, sulfamethoxazole/trimethoprim, and cefepime for persistent drainage. The patient presented to our institution two and one-half months after initial injury with continued pain and a small abscess at the medial midfoot. She was able to walk without a significant limp. Radiographs were negative for evidence of traumatic injury or foreign body (Figure 1(a)); however, MRI of the left foot had revealed a fluid collection surrounding a foreign body (Figures 1(b)–1(d)). Her laboratory markers were C-reactive protein 0.4 mg/L (normal 0.1–1.0 mg/L), erythrocytesedimentation rate 6 mm/hr (normal 0–20 mm/hr), and white blood cell count 6,800 cells/mcL (normal 4,000–13,200 cells/mcL).
Figure 1

(a) X-ray and ((b)–(d)) sagittal, axial, and coronal MRI, respectively, indicating abscess with potential foreign body.

She was taken to the operating room for irrigation and debridement. Aspiration was attempted with no significant purulence noted. The wound was explored and a 15 × 3 mm foreign body was removed (Figure 2(a)). The wound was irrigated, debrided, and closed primarily. Wound cultures were sent intraoperatively. The only organism isolated on blood and MacConkey agars was Leclercia adecarboxylata with susceptibility to multiple antibiotics and resistance to ampicillin. After consultation with pediatric infectious disease the patient was treated with a 14-day course of levofloxacin. Two months postoperatively there were no signs of continued infection or wound complications (Figure 2(b)). One year following her injury, she is without complaints.
Figure 2

(a) Foreign body removal and (b) two-month follow-up.

3. Discussion

This case presents the first time Leclercia adecarboxylata has been isolated in an immunocompetent pediatric patient. Prior reports document this bacterium in immunocompromised patients [3-8]; however, recently there have been limited reports in immunocompetent patients [9, 10] in addition to the pediatric population [5, 8, 11]. Most cases report the bacteria with excellent susceptibility to antibiotics, as was the case for this isolate; however, resistant strains have been found [12]. Even catheter-associated infection with Leclercia adecarboxylata has been treated successfully with antibiotics alone without catheter removal [13]. In our case, the retained foreign body provided a medium for the persistent indolent infection despite courses of three different antibiotics. With removal of the foreign body the persistent infection resolved with routine oral antibiotic course. This bacterium, which previously had minimal recognition, now has increasing reports and is associated with pediatric immunocompetent patients with musculoskeletal infection. This report indicates that Leclercia adecarboxylata is a potential pathogen in immunocompetent children in musculoskeletal tissue.
  13 in total

1.  [Bacterial peritonitis due to Leclercia adecarboxylata in a patient undergoing peritoneal dialysis].

Authors:  J A Rodríguez; F J Sánchez; N Gutiérrez; J E García; J A García-Rodríguez
Journal:  Enferm Infecc Microbiol Clin       Date:  2001-05       Impact factor: 1.731

2.  [Isolation of Leclercia adecarboxylata from wound exudate of a diabetic patient].

Authors:  Antonio Beltrán; Angel Vicente Molinero; Silvia Capilla; Ana María Polo; Angel Vicente
Journal:  Med Clin (Barc)       Date:  2004-02-07       Impact factor: 1.725

3.  Successful management of tunneled hemodialysis catheter-related bacteremia by Leclercia adecarboxylata without catheter removal: report of two cases.

Authors:  Mario Fernández-Ruiz; Francisco López-Medrano; Lourdes García-Sánchez; Ana García-Reyne; Teresa Ortuño de Solo; Francisca Sanz-Sanz; José María Aguado
Journal:  Int J Infect Dis       Date:  2009-04-15       Impact factor: 3.623

4.  [Biochemical study of pigmented Enterobacteriaceae].

Authors:  H LECLERC
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-06

5.  [Isolation of Leclercia adecarboxylata in ulcer exudate].

Authors:  M M Martínez; G Sánchez; J Gómez; P Mendaza; R M Daza
Journal:  Enferm Infecc Microbiol Clin       Date:  1998 Aug-Sep       Impact factor: 1.731

6.  Pneumonia due to multidrug-resistant Leclercia adecarboxylata.

Authors:  Edward H Eiland; Hafsa Siddiqui; Ann Marie Goode; Shay D Leeth
Journal:  Am J Health Syst Pharm       Date:  2013-06-01       Impact factor: 2.637

7.  [Isolation of Leclercia adecarboxylata in a cirrhotic patient].

Authors:  R M Daza; J Iborra; N Alonso; I Vera; F Portero; P Mendaza
Journal:  Enferm Infecc Microbiol Clin       Date:  1993-01       Impact factor: 1.731

Review 8.  Late-onset Leclercia adecarboxylata bacteraemia in a premature infant in the NICU.

Authors:  K A Myers; R M Jeffery; A Lodha
Journal:  Acta Paediatr       Date:  2011-08-17       Impact factor: 2.299

9.  Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis.

Authors:  O Fattal; J G Deville
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

10.  Leclercia adecarboxylata cellulitis in a child with acute lymphoblastic leukemia.

Authors:  Avnee Shah; Josephine Nguyen; Lisa M Sullivan; Kudakwashe R Chikwava; Albert C Yan; James R Treat
Journal:  Pediatr Dermatol       Date:  2011-03-08       Impact factor: 1.588

View more
  4 in total

1.  Leclercia adecarboxylata folliculitis in a healthy swimmer-An emerging aquatic pathogen?

Authors:  Alexa Broderick; Erin Lowe; Anny Xiao; Risa Ross; Richard Miller
Journal:  JAAD Case Rep       Date:  2019-08-05

2.  Leclercia adecarboxylata Causing Spontaneous Bacterial Peritonitis in a Child with Nephrotic Syndrome: A Case Report and Review of Literature.

Authors:  Ijas Hassan; Parakriti Gupta; Pallab Ray; Karalanglin Tiewsoh
Journal:  J Lab Physicians       Date:  2020-11-23

3.  Two cases of Leclercia adecarboxylata septic arthritis in immunocompetent paediatric patients.

Authors:  Ramesh Arasu; Yean Hsiang Ewe; Abavasankar Sundaram; David Anthony Foley; Anita Jane Campbell; Timothy Robin William Fletcher; Pamela Palasanthiran; Arnold Suzuki
Journal:  Access Microbiol       Date:  2022-02-28

4.  Leclercia adecarboxylata: An Emerging Pathogen Among Pediatric Infections.

Authors:  Jonathan Keyes; Evan P Johnson; Monica Epelman; Adriana Cadilla; Syed Ali
Journal:  Cureus       Date:  2020-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.